BioWorld MedTech

Nov. 17, 2011

AHA notebook: Berlin Heart unveils favorable data from Excor clinical trial

The Berlin Heart Group (Woodlands, Texas/Berlin) unveiled clinical trial data presented yesterday at the "Scientific Sessions 2011" annual meeting of the American Heart Association (AHA; Washington). Read More

CooperVision recall expanded, management credibility hit

International report: Boston Sci's Watchman implanted in first Latin American patients

Washington roundup: FDA spells out new staged IDE approval in new draft guidance

Financings roundup: Unilife prices offering, expects to raise $34M

Deals roundup: AptarGroup acquires minority interest in OVal for $3.2M

Agreements/contracts: Genisphere to supply RNA technology to Affymetrix

New ventures: Optum launches institute for sustainable health

Med-Tech Notes: Digital Assent opens more offices

HIT roundup: Methodist Hospital to deploy SciQuest's eMarketplace

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Nov. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 27, 2024.

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

AI-generated illustration of heart and metabolic impact

Bridgebio, with FDA approval, faces Pfizer in ATTR

BioWorld

With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...